Phosphoproteomics of Patient-Derived Xenographs Identifies Targets and Markers Associated with Sensitivity and Resistance to EGFR Blockade in Colorectal Cancer

0
197
Mass spectrometry–based proteomics and phosphoproteomics were performed on 30 genomically and pharmacologically characterized metastatic colorectal cancer patient–derived xenografts to investigate the molecular basis of response to EGFR blockade and identify alternative drug targets to overcome resistance.
[Science Translational Medicine]
Abstract